Synthesis and Evaluation of Bis-Thiazolium Salts as Potential Antimalarial Drug

An innovative therapeutic approach based on the use of dicationic derivatives was previously designed to inhibit the biosynthesis of phosphatidylcholine in Plasmodium spp. Among these, bis-thiazolium salts were shown to block proliferation of the malaria parasite at concentrations in the low nanomol...

Full description

Saved in:
Bibliographic Details
Published inChemMedChem Vol. 5; pp. 1102 - 1109
Main Authors Caldarelli, Sergio A., Duckert, Jean-Frédéric, Wein, Sharon, Calas, Michèle, Perigaud, Christian, Vial, Henri, Peyrottes, Suzanne
Format Journal Article
LanguageEnglish
Published Wiley-VCH Verlag 2010
Subjects
Online AccessGet full text

Cover

Loading…
Abstract An innovative therapeutic approach based on the use of dicationic derivatives was previously designed to inhibit the biosynthesis of phosphatidylcholine in Plasmodium spp. Among these, bis-thiazolium salts were shown to block proliferation of the malaria parasite at concentrations in the low nanomolar range. However, due to unsuitable molecular properties such as the presence of the two polar heads and flexibility in the linker, these compounds have low oral bioavailability. To characterize the structural requirements of the linker that lead to more rigid analogues with fewer rotatable bonds but which retain antimalarial activity, a new series of compounds incorporating an aryl moiety and eventually oxygen atoms were prepared, and their biological activity was evaluated. Structure-activity relationships suggest that the optimal linker construct is an aromatic group with two n-butyl chains branched at the para position; two new leads (compounds 39 and 40) were selected for further development.
AbstractList An innovative therapeutic approach based on the use of dicationic derivatives was previously designed to inhibit the biosynthesis of phosphatidylcholine in Plasmodium spp. Among these, bis-thiazolium salts were shown to block proliferation of the malaria parasite at concentrations in the low nanomolar range. However, due to unsuitable molecular properties such as the presence of the two polar heads and flexibility in the linker, these compounds have low oral bioavailability. To characterize the structural requirements of the linker that lead to more rigid analogues with fewer rotatable bonds but which retain antimalarial activity, a new series of compounds incorporating an aryl moiety and eventually oxygen atoms were prepared, and their biological activity was evaluated. Structure-activity relationships suggest that the optimal linker construct is an aromatic group with two n-butyl chains branched at the para position; two new leads (compounds 39 and 40) were selected for further development.
Author Duckert, Jean-Frédéric
Vial, Henri
Peyrottes, Suzanne
Caldarelli, Sergio A.
Wein, Sharon
Perigaud, Christian
Calas, Michèle
Author_xml – sequence: 1
  givenname: Sergio A.
  surname: Caldarelli
  fullname: Caldarelli, Sergio A.
  organization: Institut des Biomolécules Max Mousseron [Pôle Chimie Balard]
– sequence: 2
  givenname: Jean-Frédéric
  surname: Duckert
  fullname: Duckert, Jean-Frédéric
  organization: Institut des Biomolécules Max Mousseron [Pôle Chimie Balard]
– sequence: 3
  givenname: Sharon
  surname: Wein
  fullname: Wein, Sharon
  organization: Dynamique des interactions membranaires normales et pathologiques
– sequence: 4
  givenname: Michèle
  surname: Calas
  fullname: Calas, Michèle
  organization: Institut des Biomolécules Max Mousseron [Pôle Chimie Balard]
– sequence: 5
  givenname: Christian
  orcidid: 0000-0003-4631-6927
  surname: Perigaud
  fullname: Perigaud, Christian
  organization: Institut des Biomolécules Max Mousseron [Pôle Chimie Balard]
– sequence: 6
  givenname: Henri
  surname: Vial
  fullname: Vial, Henri
  organization: Dynamique des interactions membranaires normales et pathologiques
– sequence: 7
  givenname: Suzanne
  orcidid: 0000-0003-1705-0576
  surname: Peyrottes
  fullname: Peyrottes, Suzanne
  organization: Institut des Biomolécules Max Mousseron [Pôle Chimie Balard]
BackLink https://hal.science/hal-00616827$$DView record in HAL
BookMark eNqVijsLwjAURoMo-FydszpUb6o0cfSJg6DQ7uXSVhtJE2nSQv31VhB3p3O-jzMkXW10RsiUwZwB-IukSJO5D60DrHmHDJgIwONM8O7P-bpPhtY-AFYrwcSAXMJGuzyz0lLUKT3UqCp00mhqbnQrrRflEl9GyaqgISrXZpZejcu0k6jopkWBCsvP2JfVfUx6N1Q2m3w5IrPjIdqdvBxV_CzbuGxigzI-bc7x5wMIWCB8XrPlP-0bry5KlA
ContentType Journal Article
Copyright Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml – notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID 1XC
DOI 10.1002/cmdc.201000097
DatabaseName Hyper Article en Ligne (HAL)
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1860-7187
EndPage 1109
ExternalDocumentID oai_HAL_hal_00616827v1
GroupedDBID ---
05W
0R~
1L6
1OC
1XC
29B
31~
33P
3WU
4.4
53G
5GY
66C
6J9
77Q
8-0
8-1
A00
AAESR
AAHHS
AANLZ
AASGY
AAXRX
AAZKR
ABCUV
ABIJN
ABJNI
ABLJU
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACIWK
ACPOU
ACPRK
ACXBN
ACXQS
ADBBV
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFRAH
AHBTC
AHMBA
AITYG
AIURR
AIWBW
AJBDE
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMYDB
ASPBG
AVWKF
AZFZN
AZVAB
BDRZF
BFHJK
BMXJE
BRXPI
CS3
DCZOG
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F5P
FEDTE
G-S
GODZA
HBH
HF~
HGLYW
HHZ
HVGLF
HZ~
IX1
LATKE
LAW
LEEKS
LH4
LITHE
LOXES
LUTES
LW6
LYRES
MEWTI
MXFUL
MXSTM
MY~
O9-
OIG
P2W
P4E
PQQKQ
ROL
RWI
SUPJJ
SV3
W99
WBKPD
WOHZO
WXSBR
WYJ
XV2
YZZ
ZZTAW
~S-
ID FETCH-hal_primary_oai_HAL_hal_00616827v13
ISSN 1860-7179
IngestDate Tue Oct 15 15:36:49 EDT 2024
IsPeerReviewed true
IsScholarly true
Language English
License Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel OpenURL
MergedId FETCHMERGED-hal_primary_oai_HAL_hal_00616827v13
ORCID 0000-0003-4631-6927
0000-0003-1705-0576
0000-0003-1705-0576
0000-0003-4631-6927
ParticipantIDs hal_primary_oai_HAL_hal_00616827v1
PublicationCentury 2000
PublicationDate 2010
PublicationDateYYYYMMDD 2010-01-01
PublicationDate_xml – year: 2010
  text: 2010
PublicationDecade 2010
PublicationTitle ChemMedChem
PublicationYear 2010
Publisher Wiley-VCH Verlag
Publisher_xml – name: Wiley-VCH Verlag
SSID ssj0044818
Score 3.7975981
Snippet An innovative therapeutic approach based on the use of dicationic derivatives was previously designed to inhibit the biosynthesis of phosphatidylcholine in...
SourceID hal
SourceType Open Access Repository
StartPage 1102
SubjectTerms Chemical Sciences
Organic chemistry
Title Synthesis and Evaluation of Bis-Thiazolium Salts as Potential Antimalarial Drug
URI https://hal.science/hal-00616827
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db5swELei7qUv07a2Wre1sqqqUpW4JYQQeMySRjT9ipps6ltkwCRICUyEVEr_lP61u8PEEClSu71gMB_C3E_nu_PdD0JOeT3weN21mcZbBjNsy2euUdeZHdiGpblcN32sRr67N51fRv-p-VSpvJaylpape-G9bK0r-R-pQh_IFatk_0Gy6qHQAfsgX9iChGH7LhkPVxHYb0gpguHvK0XcjRbgz3DBRtOQv8SzcDmvDvksXeBPZQZxiglCKBlo5hw8WzzoJstJ2VBFIoE74WNTLFPMfJ4ggWcWMhXJJIyr7YvCFFYFQH3BI9bLF-F92SShV6wCSeICJIsusgA6WNG5zuTP7rHy0eZBiTwxVSk99rvjVEvxSKlaLVNj4DxKBSnKffmUm-vjZkmfgnGil-ZmpEfdqvclj6w3970sWy8rTylmuPWqvtMejgfd3vj2-v5m86xi2nbat-MpAAFNO9PSW8_gWX_QQYlhumj3UVGTgVebxY7VqNaEoJp-ufkaYLRM10H6zGgZfSIfc2-DtiV0PpOKiL6Qs4GkK1_V6KiovlvU6BkdFETmqz3yoPBFAV-0wBeNA7qJL5rhi_IFVfiiZXxRxNc-Oe9djToOw6H_kTQn4-2fo3FAdqI4El8J9YSv-7whtKblGoFt2oErTDewPfxJgVHnh-Tk7ed9e89F38muzNrA0NcPspMmS3EExmDqHmdS-QtbumR9
link.rule.ids 230,315,783,787,888,4031,27935,27936,27937
linkProvider Wiley-Blackwell
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synthesis+and+Evaluation+of+Bis-Thiazolium+Salts+as+Potential+Antimalarial+Drug&rft.jtitle=ChemMedChem&rft.au=Caldarelli%2C+Sergio+A.&rft.au=Duckert%2C+Jean-Fr%C3%A9d%C3%A9ric&rft.au=Wein%2C+Sharon&rft.au=Calas%2C+Mich%C3%A8le&rft.date=2010&rft.pub=Wiley-VCH+Verlag&rft.issn=1860-7179&rft.eissn=1860-7187&rft.volume=5&rft.spage=1102&rft.epage=1109&rft_id=info:doi/10.1002%2Fcmdc.201000097&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=oai_HAL_hal_00616827v1
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1860-7179&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1860-7179&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1860-7179&client=summon